Real-Time Monitoring of Arsenic Trioxide Release and Delivery by Activatable T-1 Imaging
Real-Time Monitoring of Arsenic Trioxide Release and Delivery by Activatable T-1 Imaging
复制标题
通过可激活 T1 成像实时监测三氧化二砷的释放和输送
DOI:
10.1021/nn506640h
复制
发表时间:
2015
期刊:
影响因子:
17.1
通讯作者:
Gao Jinhao
中科院分区:
文献类型:
--
作者:
Zhao Zhenghuan;Wang Xiaomin;Zhang Zongjun;Zhang Hui;Liu Hanyu;Zhu Xianglong;Li Hui;Chi Xiaoqin;Yin Zhenyu;Gao Jinhao
Delivery of arsenic trioxide (ATO), a clinical anticancer drug, has drawn much attention to improve its pharmacokinetics and bioavailability for efficient cancer therapy. Real-time andin situmonitoring of ATO behaviorsin vivois highly desirable for efficient tumor treatment. Herein, we report an ATO-based multifunctional drug delivery system that efficiently delivers ATO to treat tumors and allows real-time monitoring of ATO release by activatable T1imaging. We loaded water-insoluble manganese arsenite complexes, the ATO prodrug, into hollow silica nanoparticles to form a pH-sensitive multifunctional drug delivery system. Acidic stimuli triggered the simultaneous release of manganese ions and ATO, which dramatically increased the T1signal (bright signal) and enabled real-time visualization and monitoring of ATO release and delivery. Moreover, this smart multifunctional drug delivery system significantly improved ATO efficacy and strongly inhibited the growth of solid tumors without adverse side effects. This strategy has great potential for real-time monitoring of theranostic drug delivery in cancer diagnosis and therapy.